Celsius (NASDAQ:CELH – Free Report) had its price target upped by Piper Sandler from $44.00 to $45.00 in a research note issued to investors on Wednesday morning, Marketbeat Ratings reports. Piper Sandler currently has an overweight rating on the stock.
Several other analysts have also recently commented on CELH. Stifel Nicolaus reduced their price objective on shares of Celsius from $45.00 to $37.00 and set a “buy” rating for the company in a research note on Monday, February 10th. Truist Financial upgraded shares of Celsius from a “hold” rating to a “buy” rating and raised their price objective for the company from $35.00 to $45.00 in a research note on Monday, March 31st. Roth Mkm restated a “buy” rating and set a $38.00 target price on shares of Celsius in a research report on Friday, February 21st. LADENBURG THALM/SH SH cut their target price on shares of Celsius from $62.00 to $58.00 and set a “neutral” rating for the company in a research report on Thursday, March 27th. Finally, B. Riley restated a “buy” rating and set a $49.00 target price (up previously from $44.00) on shares of Celsius in a research report on Friday, February 21st. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, Celsius currently has an average rating of “Moderate Buy” and a consensus target price of $46.94.
View Our Latest Research Report on CELH
Celsius Stock Performance
Celsius (NASDAQ:CELH – Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.18 EPS for the quarter, missing the consensus estimate of $0.20 by ($0.02). Celsius had a return on equity of 51.89% and a net margin of 10.70%. The firm had revenue of $329.28 million during the quarter, compared to analyst estimates of $349.09 million. During the same quarter last year, the business posted $0.27 EPS. The firm’s revenue was down 7.4% on a year-over-year basis. Equities analysts forecast that Celsius will post 0.89 earnings per share for the current fiscal year.
Insider Transactions at Celsius
In other news, Director Joyce Russell sold 4,000 shares of Celsius stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $28.47, for a total transaction of $113,880.00. Following the completion of the sale, the director now directly owns 19,106 shares in the company, valued at $543,947.82. The trade was a 17.31% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 2.55% of the company’s stock.
Institutional Investors Weigh In On Celsius
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Geneos Wealth Management Inc. grew its holdings in Celsius by 30.4% in the first quarter. Geneos Wealth Management Inc. now owns 26,804 shares of the company’s stock valued at $955,000 after purchasing an additional 6,250 shares during the period. Bayforest Capital Ltd purchased a new stake in Celsius in the first quarter valued at approximately $647,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Celsius by 14.2% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 433,241 shares of the company’s stock valued at $15,432,000 after purchasing an additional 53,844 shares during the period. United Services Automobile Association purchased a new stake in Celsius in the first quarter valued at approximately $334,000. Finally, Meiji Yasuda Asset Management Co Ltd. purchased a new stake in Celsius in the first quarter valued at approximately $254,000. 60.95% of the stock is currently owned by hedge funds and other institutional investors.
About Celsius
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Further Reading
- Five stocks we like better than Celsius
- Bank Stocks – Best Bank Stocks to Invest In
- Intuit’s AI Boom: Stock Soaring, But Should Investors Hit Pause?
- P/E Ratio Calculation: How to Assess Stocks
- Top Dividend Plays With Strong Analyst Ratings
- How to Effectively Use the MarketBeat Ratings Screener
- Robinhood Stock Keeps Giving Investors Reasons To Buy
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.